MARINA VERONESI

Dr. MARINA VERONESI

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2001 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
CDClaudio Dalvit
Claudio Dalvit
GFGianPaolo Fogliatto
GianPaolo Fogliatto
ASAlbert Stewart
Albert Stewart
MVMARINA VERONESI
MARINA VERONESI
Brian J. StockmanBrian J. Stockman
Brian J. Stockman

1 September 2000 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
CDClaudio Dalvit
Claudio Dalvit
PPPaolo Pevarello
Paolo Pevarello
MTMarco Tatò
Marco Tatò
MVMARINA VERONESI
MARINA VERONESI
AVAnna Vulpetti
Anna Vulpetti
MSMichael Sundström
Michael Sundström


27 March 2006 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
JTJean‐Yves Trosset
Jean‐Yves Trosset
CDClaudio Dalvit
Claudio Dalvit
SKStefan Knapp
Stefan Knapp
MFMarina Fasolini
Marina Fasolini
MVMARINA VERONESI
MARINA VERONESI
JMJürgen K. Moll
Jürgen K. Moll

13 January 2017 in Scientific Reports
Verified
Journal Article
Open access
Nicoletta PlotegherNicoletta Plotegher
Nicoletta Plotegher
GBG. Berti
G. Berti
EFEmanuele Ferrari
Emanuele Ferrari
ITI. Tessari
I. Tessari
MZM. Zanetti
M. Zanetti
LBLuigi Bubacco
Luigi Bubacco
Parkinson’s disease is a neurodegenerative disorder characterized by the death of dopaminergic neurons and by accumulation of alpha-synuclein (aS) aggregates in the surviving neurons. The dopamine catabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) is a highly reactive and toxic molecule that leads to aS oligomerization by covalent modifications to lysine residues. Here we show that DOPAL-induced aS oligomer formation in neurons is associated with damage of synaptic vesicles, and with alterations in the synaptic vesicles pools. To investigate the molecular mechanism that leads to synaptic impairment, we first aimed to characterize the biochemical and biophysical properties of the aS-DOPAL oligomers; heterogeneous ensembles of macromolecules able to permeabilise cholesterol-containing lipid membranes. aS-DOPAL oligomers can induce dopamine leak in an in vitro model of synaptic vesicles and in cellular models. The dopamine released, after conversion to DOPAL in the cytoplasm, could trigger a noxious cycle that further fuels the formation of aS-DOPAL oligomers, inducing neurodegeneration.

6 June 2002 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CDClaudio Dalvit
Claudio Dalvit
MFMaria Flocco
Maria Flocco
SKStefan Knapp
Stefan Knapp
MMMarina Mostardini
Marina Mostardini
RPRita Perego
Rita Perego
MVMario Varasi
Mario Varasi